MedTrace Logo

Risk Evaluation by COronary CTA and Artificial IntelliGence Based fuNctIonal analyZing tEchniques - II

NCT05856110 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2023-08-08

No results posted yet for this study

Summary

This study is a multicenter, prospective clinical cohort study. The study intends to continuously enroll patients with coronary heart disease. All subjects will undergo coronary CTA (followed by anatomic, functional and radiomics analysis), proteomics research as well as clinical follow-up of cardiovascular events. The purpose of this study is to establish a new, non-invasive cardiovascular disease risk stratification system.

Conditions

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Ruiyan Zhang, M.D., Ph.D. · Ruijin Hospital

  • Lin Lu, M.D. · Ruijin Hospital

  • Fei Ye, M.D. · First Hospital of Nanjing

  • Yachen Zhang, M.D. · Xinhua Hospital, Shanghai Jiaotong University School of Medicine

  • Tian Xie, M.D. · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

  • Lei Liu, M.D. · First Affiliated Hospital of Harbin Medical University

  • Xiaolei Yang, M.D. · The First Affiliated Hospital of Dalian Medical University

  • Run Guo, M.D. · Cangzhou Center Hospital

  • Yingying Guo, M.D. · The First Affiliated Hospital of Zhengzhou University

  • Geng Wang, M.D. · The General Hospital of Northern Theater Command

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-03
Primary Completion
2025-09-30
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05856110 on ClinicalTrials.gov